TP53 and neoplasm: Therefore, phosphorylated USP10 can inhibit the growth of tumour cells without inducing mutations in p53, which implies that phosphorylation of USP10 has a potential therapeutic effect against tumours (Mueller et al., 2009; Yuan et al., 2010; Herhaus et al., 2015).